IBDEI0PM ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12562,2)
 ;;=^295223
 ;;^UTILITY(U,$J,358.3,12563,0)
 ;;=V10.3^^70^769^4
 ;;^UTILITY(U,$J,358.3,12563,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12563,1,1,0)
 ;;=1^V10.3
 ;;^UTILITY(U,$J,358.3,12563,1,8,0)
 ;;=8^Hx Of Breast Malignancy
 ;;^UTILITY(U,$J,358.3,12563,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,12564,0)
 ;;=V10.41^^70^769^15
 ;;^UTILITY(U,$J,358.3,12564,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12564,1,1,0)
 ;;=1^V10.41
 ;;^UTILITY(U,$J,358.3,12564,1,8,0)
 ;;=8^Hx-Cervical Malignancy
 ;;^UTILITY(U,$J,358.3,12564,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,12565,0)
 ;;=V10.42^^70^769^34
 ;;^UTILITY(U,$J,358.3,12565,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12565,1,1,0)
 ;;=1^V10.42
 ;;^UTILITY(U,$J,358.3,12565,1,8,0)
 ;;=8^Hx-Uterus Malignancy Nec
 ;;^UTILITY(U,$J,358.3,12565,2)
 ;;=^295220
 ;;^UTILITY(U,$J,358.3,12566,0)
 ;;=V10.43^^70^769^11
 ;;^UTILITY(U,$J,358.3,12566,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12566,1,1,0)
 ;;=1^V10.43
 ;;^UTILITY(U,$J,358.3,12566,1,8,0)
 ;;=8^Hx Of Ovarian Malignancy
 ;;^UTILITY(U,$J,358.3,12566,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,12567,0)
 ;;=V10.44^^70^769^18
 ;;^UTILITY(U,$J,358.3,12567,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12567,1,1,0)
 ;;=1^V10.44
 ;;^UTILITY(U,$J,358.3,12567,1,8,0)
 ;;=8^Hx-Female Genit Malg Nec
 ;;^UTILITY(U,$J,358.3,12567,2)
 ;;=^295222
 ;;^UTILITY(U,$J,358.3,12568,0)
 ;;=V10.81^^70^769^2
 ;;^UTILITY(U,$J,358.3,12568,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12568,1,1,0)
 ;;=1^V10.81
 ;;^UTILITY(U,$J,358.3,12568,1,8,0)
 ;;=8^Hx Of Bone Malignancy
 ;;^UTILITY(U,$J,358.3,12568,2)
 ;;=^295239
 ;;^UTILITY(U,$J,358.3,12569,0)
 ;;=V10.82^^70^769^25
 ;;^UTILITY(U,$J,358.3,12569,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12569,1,1,0)
 ;;=1^V10.82
 ;;^UTILITY(U,$J,358.3,12569,1,8,0)
 ;;=8^Hx-Malig Skin Melanoma
 ;;^UTILITY(U,$J,358.3,12569,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,12570,0)
 ;;=V10.83^^70^769^31
 ;;^UTILITY(U,$J,358.3,12570,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12570,1,1,0)
 ;;=1^V10.83
 ;;^UTILITY(U,$J,358.3,12570,1,8,0)
 ;;=8^Hx-Skin Malignancy Nec
 ;;^UTILITY(U,$J,358.3,12570,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,12571,0)
 ;;=V10.84^^70^769^6
 ;;^UTILITY(U,$J,358.3,12571,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12571,1,1,0)
 ;;=1^V10.84
 ;;^UTILITY(U,$J,358.3,12571,1,8,0)
 ;;=8^Hx Of Eye Malignancy
 ;;^UTILITY(U,$J,358.3,12571,2)
 ;;=^295242
 ;;^UTILITY(U,$J,358.3,12572,0)
 ;;=V10.85^^70^769^3
 ;;^UTILITY(U,$J,358.3,12572,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12572,1,1,0)
 ;;=1^V10.85
 ;;^UTILITY(U,$J,358.3,12572,1,8,0)
 ;;=8^Hx Of Brain Malignancy
 ;;^UTILITY(U,$J,358.3,12572,2)
 ;;=^295243
 ;;^UTILITY(U,$J,358.3,12573,0)
 ;;=V10.86^^70^769^26
 ;;^UTILITY(U,$J,358.3,12573,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12573,1,1,0)
 ;;=1^V10.86
 ;;^UTILITY(U,$J,358.3,12573,1,8,0)
 ;;=8^Hx-Malign Nerve Syst Nec
 ;;^UTILITY(U,$J,358.3,12573,2)
 ;;=^295244
 ;;^UTILITY(U,$J,358.3,12574,0)
 ;;=V10.88^^70^769^16
 ;;^UTILITY(U,$J,358.3,12574,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12574,1,1,0)
 ;;=1^V10.88
 ;;^UTILITY(U,$J,358.3,12574,1,8,0)
 ;;=8^Hx-Endocrine Malign Nec
 ;;^UTILITY(U,$J,358.3,12574,2)
 ;;=^295246
 ;;^UTILITY(U,$J,358.3,12575,0)
 ;;=A4220^^71^770^1^^^^1
 ;;^UTILITY(U,$J,358.3,12575,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12575,1,1,0)
 ;;=1^A4220
 ;;^UTILITY(U,$J,358.3,12575,1,3,0)
 ;;=3^Infusion Pump Refill Kit
 ;;^UTILITY(U,$J,358.3,12576,0)
 ;;=99195^^71^771^1^^^^1
 ;;^UTILITY(U,$J,358.3,12576,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12576,1,1,0)
 ;;=1^99195
